Neuromed Cream
NDC 54723-722
Product Information
Neuromed (benzocaine) is a OTC MONOGRAPH DRUG-approved product labeled by Sambria Pharmaceuticals, Inc.. This medication is typically used as a allergens [cs]. It is supplied as a cream for topical administration. This product entry covers the primary NDC 54723-722 and 3 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
- Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
- Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 54723-722?
What are the uses of this product?
What are Active Ingredients of this product?
- BENZOCAINE 20 mg/100mg - A surface anesthetic that acts by preventing transmission of impulses along NERVE FIBERS and at NERVE ENDINGS.
- BENZOCAINE 20 mg/100mg - A surface anesthetic that acts by preventing transmission of impulses along NERVE FIBERS and at NERVE ENDINGS.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- BENZOCAINE (UNII: U3RSY48JW5)
- BENZOCAINE (UNII: U3RSY48JW5) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- WATER (UNII: 059QF0KO0R)
- ARNICA MONTANA FLOWER (UNII: OZ0E5Y15PZ)
- C13-14 ISOPARAFFIN (UNII: E4F12ROE70)
- MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
- CETEARETH-25 (UNII: 8FA93U5T67)
- CHONDROITIN SULFATE SODIUM (BOVINE) (UNII: 8QTV3DTT8W)
- DOCUSATE SODIUM (UNII: F05Q2T2JA0)
- EMU OIL (UNII: 344821WD61)
- DIETHYLENE GLYCOL MONOETHYL ETHER (UNII: A1A1I8X02B)
- ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)
- GLUCOSAMINE SULFATE (UNII: 1FW7WLR731)
- GLYCERIN (UNII: PDC6A3C0OX)
- ISOPROPYL PALMITATE (UNII: 8CRQ2TH63M)
- LAURETH-7 (UNII: Z95S6G8201)
- MELALEUCA ALTERNIFOLIA LEAF (UNII: G43C57162K)
- DIMETHYL SULFONE (UNII: 9H4PO4Z4FT)
- PHENOXYETHANOL (UNII: HIE492ZZ3T)
- POLYACRYLAMIDE (10000 MW) (UNII: E2KR9C9V2I)
- POLYSORBATE 20 (UNII: 7T1F30V5YH)
- SAFFLOWER OIL (UNII: 65UEH262IS)
- STEARIC ACID (UNII: 4ELV7Z65AP)
- TROLAMINE (UNII: 9O3K93S3TK)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 723562 - benzocaine 20 % Topical Cream
- RxCUI: 723562 - benzocaine 200 MG/ML Topical Cream
Which are the Pharmacologic Classes of this product?
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Standardized Chemical Allergen - [EPC] (Established Pharmacologic Class)
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Standardized Chemical Allergen - [EPC] (Established Pharmacologic Class)
* Please review the full disclaimer at the bottom of this page.